Author: Kotwani, A.

Source: The International Journal of Tuberculosis and Lung Disease, Volume 13, Number 5, May 2009 , pp. 574-579(6)

Publisher: International Union Against Tuberculosis and Lung Disease

Abstract:

SETTING: States of Haryana, Karnataka, Maharashtra and Rajasthan, and Chennai (capital of Tamil Nadu State), India.

OBJECTIVE: To assess the availability, price and affordability of beclomethasone and salbutamol inhalers in five Indian states using a standardised methodology.

DESIGN: Data on the availability and price of two essential medicines for asthma, beclomethasone (50 μg/dose) and salbutamol (0.1 mg/dose) inhalers, were collated from five medicine price studies on essential medicines.

RESULTS: Beclomethasone and salbutamol inhalers were available in 25% and 30% of public facilities in Rajasthan State only. The procurement price for beclomethasone and salbutamol was respectively 0.74 and 0.56 times the international reference price (IRP). The availability of beclomethasone inhalers was poor in the private sector (10-65%) in four states. The availability of salbutamol inhalers ranged from 20% to 95% as an innovator brand and 83% to 100% as the generic. The price of beclomethasone was 0.87-1.49 times the IRP, while salbutamol cost 0.82-1.12 times the IRP. Purchasing one inhaler each of salbutamol and beclomethasone cost between 1.6 and 2.3 days' wages for the lowest paid government worker. Eighty per cent of the population earn less than this wage.

CONCLUSIONS: Essential inhalation medicines for asthma were not available in the public sector where low-income populations receive treatment. Steroid inhalers were not readily available in the private sector. Essential inhalation medicines for asthma are not affordable for the majority of the population.

Keywords: access to medicines; asthma; chronic diseases; India; inhalation medicines

Document Type: Regular paper

Affiliations: 1: Department of Pharmacology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India

Publication date: 2009-05-01

More about this publication?

• The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on tuberculosis and lung health world-wide.

  Certain IJTLD articles are selected for translation into French, Spanish, Chinese or Russian. They are available on the Union website

• Editorial Board
• Information for Authors
• Subscribe to this Title
• ingentaconnect is not responsible for the content or availability of external websites

Related content

• In this: publication
• By this: publisher
• In this Subject: Internal Medicine
• By this author: Kotwani, A.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers